Consistently with the presence of obesity, patients in the subcutaneous semaglutide group also showed higher WC ( p = 0.0002) and systolic blood pressure ( p = 0.033), but similar diastolic blood pressure (Fig.S1eg)
What to Expect During Treatment Starting a combined regimen is a journey of start low and go slow. Most providers will start you on the lowest possible dose of a GLP-1 medication to see how your stomach handles it
Consult your prescribing clinician to verify you're on the appropriate maintenance dose, review your medication list, and consider investigations such as thyroid function tests if clinically indicated
They also had a body mass index of thirty or higher, which falls into the medical category of obesity
Experimental and therapeutic medicine , 21 (2), 125
GLP-1 has been proven to be a useful adjuvant therapy in type-2 diabetes mellitus, metabolic syndrome, and hyperglycemia